Results 31 to 40 of about 52,757 (299)
Role of gangliosides in prostate pathology [PDF]
Romanian Journal of Infectious Diseases, 2016 Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae +2 more
doaj +1 more source
Preclinical and clinical investigations as an approach to rational phytotherapy in prostate diseases [PDF]
, 2004 Phytotherapeuticals have gained widespread usage in the treatment of symptomatic benign prostatic hyperplasia (BPH). Among these phytotherapeutics, the most popular and extensively studied are extracts of the dried ripe fruit of Serenoa repens (SRE ...
Weisskopf, Marianne
core +1 more source
Prostate International, 2018 Background: To investigate the effect of asymptomatic inflammatory prostatitis on clinical outcomes of patients undergoing trans urethral resection of prostate due to benign prostatic hyperplasia.
Suleyman Sami Cakir +5 more
doaj +1 more source
A COMPARISON OF TRANSURETHRAL RESECTION OF THE PROSTATE AND MEDICAL TREATMENT FOR THE PATIENT WITH MODERATE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA [PDF]
, 1996 1996-03-29Transurethral resection of the prostate is the most common surgical treatment for benign prostatic hyperplasia. We conducted a prospective randomized clinical trial to compare this surgery with medical treatment in men with moderate symptoms of
MIYAKE, KOJI +2 more
core +1 more source
Alexandria Journal of Medicine, 2018 Prostatic hyperplasia is benign tumor occur in prostate. Benign prostatic hyperplasia is common disease in old men. The incidence of disease arises with increase in age.
Mustafa F. Dawood +2 more
doaj +1 more source
PLoS ONE, 2022 Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels ...
Jinho An, Hyunseok Kong
doaj +1 more source
Portal Hypertension Secondary to Benign Prostatic Hyperplasia [PDF]
, 2022 Benign prostatic hyperplasia (BPH) obstructs the bladder outlet. Patients with BPH frequently present with lower urinary tract symptoms. However, patients with BPH can present with serious fatal complications unless diagnosed and treated sufficiently. In
Emrullah Söğütdelen +3 more
core +1 more source
Expert consensus on Rezūm™: Indications, surgical technique and postoperative care
BJUI CompassBackground Lower urinary tract symptoms associated to benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated to a high clinical, economic and humanistic burden.
Emilio López Alcina +4 more
doaj +1 more source
Effect of Educational Guidelines Application on Quality of life among Geriatric Patients having Benign Prostatic Hyperplasia [PDF]
Egyptian Journal of Health CareBackground: Benign prostatic hyperplasia is one of the most prevalent disorders in elderly men and non-malignant condition of the prostate, increases morbidity, often resulting in lower urinary tract symptoms, which can have an undesirable influence on a
Laila Awadin Ali Hassan +5 more
doaj +1 more source
Advanced Science, EarlyView.Single‐cell longitudinal profiling reveals that androgen‐deprivation therapy induces a DPT+ fibroblast‐complement axis that suppresses macrophage inflammation and drives CD8+ T cell exhaustion in prostate cancer. Concurrently, resistant epithelial subpopulations persist and engage TSPAN1‐ and NRXN1‐mediated programs promoting CRPC and neuroendocrine ...
Yang Chen +19 more
wiley +1 more source